Browse All

Current Filters

CLEAR FILTER x

TITLE

Cross-Reactive Antibodies to Butyrophilins in Myelin Oligodendrocyte Glycoprotein Antibody Disease.

Author:Nishiyama, Shuhei   Mikami, Takahisa   Bilodeau, Philippe-Antoine   Anderson, Monique   Bobrowski-Khoury, Natasha   Drosu, Natalia   Levy, Michael   

Session Name:P7: Autoimmune Neurology: NMOSD and MOGAD 1  

Topic:Autoimmune Neurology  

Program Number:P7.020  

Author Institution:Tohoku University Graduate school of Medicine, Sendai, Japan  Massachusetts General Hospital, Cambridge, MA  Massachusetts General Hospital, Boston, MA  Mass General Hospital, Boston, MA  Mass General Hospital/Harvard Medical School, Cambridge, MA  Massachusetts General Hospital/Harvard Medical School, Boston, MA  

The Prevalence of Sjogren’s Syndrome-associated Antibodies and Sjogren’s Syndrome in patients with anti-Myelin Oligodendrocyte Glycoprotein Antibodies

Author:Wruble, Mattia   Bilodeau, Philippe-Antoine   Vishnevetsky, Anastasia   Anderson, Monique   Mikami, Takahisa   Salky, Rebecca   Romanow, Gabriela   Chitnis, Tanuja   Levy, Michael   Bhattacharyya, Shamik   

Session Name:P8: Autoimmune Neurology: Immune Therapy Complications, Neurorheumatology, and Other Inflammatory Disorders  

Topic:Autoimmune Neurology  

Program Number:P8.018  

Author Institution:Mass General Brigham, Somerville, MA  Mass General Brigham, Boston, MA  Massachusetts General Hospital, Boston, MA  Massachusetts General Hospital, Cambridge, MA  Brigham and Women'S Hospital, Boston, MA  

Comparative Analysis of Disease-modifying Treatments for Double Seronegative Neuromyelitis Optica Spectrum Disorder

Author:Mahler, Joao Vitor   Vallejos, Gerome   Mikami, Takahisa   Bilodeau, Philippe-Antoine   Silva, Guilherme   Apostolos-Pereira, Samira   Leles, Bruna   Manzano, Giovanna   Gibbons, Emily   Uawitha, Ekdanai   Ramprasad, Manisha   Sezen, Ahmetcan   Pasquale, Olivia   Kim, Angie   Vij, R   

Session Name:P9: Multiple Sclerosis: NMOSD, MOGAD, and Other Mimickers of MS  

Topic:Multiple Sclerosis  

Program Number:P9.010  

Author Institution:Division of Neuroimmunology & Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, BOSTON, MA  Division of Neuroimmunology & Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, New York, NY  Division of Neuroimmunology & Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Cambridge, MA  Departamento de Neurologia, Hospital das Clínicas da Faculdade de Medicina da USP, SÃO PAULO, Brazil  Departamento de Neurologia, Hospital das Clínicas da Faculdade de Medicina da USP, Sao Paulo, Brazil  Walton Centre NHS Foundation Trust, Liverpool, United Kingdom  Case Western Reserve University School of Medicine, Cleveland, Ohio, Cleveland Heights, OH  Koç University, Istanbul, Turkey  NYU Grossman School of Medicine, New York, NY  NYU School of Medicine, New York, NY  Koc University School of Medicine, Istanbul, Turkey  Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center, Cleveland, OH  Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates